KRAS Vaccine with Poly-ICLC adjuvant
J2456
Phase 1 small_molecule active
Quick answer
KRAS Vaccine with Poly-ICLC adjuvant for Colorectal Cancer is a Phase 1 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Colorectal Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active